ArticleAlimentary pharmacology & therapeutics2025

Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation.

Simone Chin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.